Live Breaking News & Updates on Lund May

Stay updated with breaking news from Lund may. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Active Biotech: FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration (FDA) has granted tasquinimod Orphan Drug Designation for the treatment of myelofibrosis. "The ....

Hans Kolam , Loncode Institute , Erasmus University Medical Center , Drug Administration , Lund May , Nasdaq Stockholm , Orphan Drug Designation , Drug Designation , Active Biotech ,